PharmAust Seeks EU Orphan Status for ALS Drug
PremiumCompany AnnouncementsPharmAust Seeks EU Orphan Status for ALS Drug
2M ago
PharmAust Limited Announces 2024 Hybrid AGM
Premium
Company Announcements
PharmAust Limited Announces 2024 Hybrid AGM
2M ago
PharmAust Limited Expands Share Capital
Premium
Company Announcements
PharmAust Limited Expands Share Capital
2M ago
PharmAust Sets AGM Date, Eyes FDA Approval
PremiumCompany AnnouncementsPharmAust Sets AGM Date, Eyes FDA Approval
3M ago
PharmAust Issues New Shares, Advances ALS Treatment
Premium
Company Announcements
PharmAust Issues New Shares, Advances ALS Treatment
4M ago
Pharmaust Limited Expands Investor Horizons
Premium
Company Announcements
Pharmaust Limited Expands Investor Horizons
4M ago
PharmAust’s Monepantel Advances in ALS Trial
PremiumCompany AnnouncementsPharmAust’s Monepantel Advances in ALS Trial
4M ago
PharmAust Limited Plans Investor Sessions on Clinical Study
Premium
Company Announcements
PharmAust Limited Plans Investor Sessions on Clinical Study
4M ago
PharmAust Limited Eyes Growth in Neurodegenerative Market
Premium
Company Announcements
PharmAust Limited Eyes Growth in Neurodegenerative Market
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100